Moreover, heterozygous mutations in Fanconi anaemia genes are associated with increased cancer risk, primarily BC (Mathew, 2006; Alan & D'Andrea, 2010), and indeed, two of the four AJP-specific deleterious variants in the EPPK1 gene were also detected in the high-risk BC cohort. This evidence concerns the gene EPPK1 and cancer.